Xpresspa group, inc. (XSPA)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Cash flows from operating activities
Consolidated net loss

-20,530

-36,746

-28,389

-24,003

-11,258

-109,677

-

-

-

Consolidated net loss from discontinued operations

-

-1,115

-12,277

-4,724

-

-

-

-

-

Loss from continuing operations

-20,530

-35,631

-16,112

-19,279

-

-

-

-

-

Net loss

-

-

-

-

-

-

-52,433

-20,841

-7,479

Adjustments to reconcile consolidated net loss from continuing operations to net cash used in operating activities:
Depreciation and amortization

6,124

7,398

7,976

1,317

3,516

-

-

-

-

Impairment/disposal of long-lived assets

4,106

2,100

-

-

-

-

-

-

-

Gain on restructuring of venture loan

-

-

-

-

-

-

-

-

963

Loss on extinguishment of debt

-

-

-

-356

-1,707

-

-

-

-

Conversion of shares of preferred stock to shares of Common Stock

-

-

1

0

-

-

-

-

-

Revaluation of warrants and conversion options

-2,170

-1,520

-

-

-

-

0

2,883

-

Debt conversion expense

1,584

0

-

-

-

-

-

-

-

Impairment of cost investments

-1,984

0

-

-

-

-

-

-

-

Issuance of Series F Convertible Preferred Stock

1,131

0

-

-

-

-

-

-

-

Change in deferred tax assets and liabilities

-

-

-

-

-866

0

0

-58

24

Depreciation and amortization

-

-

-

-

-

4,023

5,220

2,501

61

Amortization of debt discount and debt issuance costs

1,031

986

0

1,871

2,159

-

-

-

-

Increase (decrease) in accrued severance pay

-

-

-

-

-

-

-

-

-177

Stock-based compensation

335

916

2,177

2,448

5,064

10,967

12,093

8,087

1,769

Issuance of shares of common stock related to the acquisition of IDG

-

-

-

-

17

-

-

-

-

Accrued interest expense

-

-

-

-

-

-

-

-

98

Amortization of debt discount

-

-

-

-

-

0

-

-

1,280

Amortization of deferred finance charges

-

-

-

-

-

0

-

-

-

Issuance of warrants

689

64

0

-281

114

65

-

-

-

Accretion of interest

958

0

-

-

-

-

-

-

-

Issuance of shares for extinguishment of debt

-

-

-

-

-

0

-

-

-

Issuance of shares of Common Stock for services

-

247

27

65

0

0

-

-

-

Issuance of Common Stock for repayment of debt and interest

-

-

0

-

-

-

-

-

-

Issuance of Common Stock for payment of interest

105

310

-

-

-

-

-

-

-

Impairment of goodwill and investment

-

19,630

0

11,937

0

67,112

7,253

0

-

Gain on disposal of assets

-

-

148

-

-

-

-

-

-

Royalties settled by disposal of assets

-

-

-

-1,750

0

-

-

-

-

Gain on disposal of assets

-

-

-

564

0

-

-

-

-

Change in fair value of derivative warrant liabilities

-

-

-225

-158

2,544

-2,201

-

-

-

Contingent liability as a result of acquisition

-

-

316

0

-

-

-

-

-

Gain on the sale of patents

-

450

0

-

-

-

-

-

-

Repayment on account of venture loan

-

-

-

-

-

-

-

-

2,095

Assignment of patents

-

-

-

-

-

-

100

0

-

Change in fair value of derivative warrant liabilities and conversion feature

-

-

-

-

-

-

-1,196

6,847

-402

Exchange rate loss, net

-

-

-

89

-346

-192

97

-8

-29

Changes in assets and liabilities:
Decrease in inventory

-136

-377

-

-

-

-

-

-

-

Increase in accounts receivable, net

-

-

-

-

0

-

-

-

-

(Increase) decrease in inventory

-

-

-1,347

-74

146

-

-

-

-

Decrease (increase) in other current assets and other assets

-644

1,835

636

-284

97

-374

135

208

283

Increase (decrease) in accounts payable, accrued expenses and other current liabilities

3,760

-604

-3,114

-2,880

378

763

3,538

7

-141

Increase (decrease) in deferred revenue

-

-

-

-

2

-

-

-

-

Decrease in other liabilities

-

-55

-368

-280

-963

-

-

-

-

Net cash used in operating activities - continuing operations

-113

-8,067

-8,761

-3,429

-2,571

-

-

-

-

Net cash provided by operating activities - discontinued operations

-

1,501

-3,411

-5,012

-

-

-

-

-

Net cash used in operating activities

-113

-6,566

-12,172

-8,441

-

-28,382

-23,465

-14,468

-5,380

Cash flows from investing activities:
Increase in deposits

-

-

-

-

-

-

-

-

-1

Cash acquired as part of acquisition

-

-

26

2,114

144

0

0

3,326

-

Acquisition of property and equipment

2,275

3,031

4,479

66

0

246

23

208

27

Acquisition of software

-

85

233

0

-

-

1,420

22,548

-

Proceeds from the sale of subsidiary

-

800

250

0

-

-

-

-

-

Proceeds from the sale of cost method investment

-

200

0

-

-

-

-

-

-

Proceeds from the sale of patents

-

250

150

0

-

-

-

-

-

Decrease (increase) in deposits

-

-

-

-2,001

248

2,404

-

-

-

Net cash used in investing activities - continuing operations

-2,275

-1,866

-4,286

4,049

-104

-

-

-

-

Net cash used in investing activities - discontinued operations

-

0

-1,110

-575

-

-

-

-

-

Increase in deposits

-

-

-

-

-

-

193

46

-

Investment in restricted short-term deposits and cash equivalents

-

-

-

-

-

-

-

-

-20

Net cash used in investing activities

-2,275

-1,866

-5,396

3,474

-

-2,650

-1,636

-19,476

-6

Cash flows from financing activities:
Proceeds from the issuance of note to Calm

2,500

0

-

-

-

-

-

-

-

Proceeds from convertible notes and warrants

-

4,350

0

-

-

-

-

-

-

Net proceeds from senior secured convertible notes and warrants

-

-

-

-

12,425

0

-

-

-

Exercise of stock options

-

-

-

-

-

2,160

974

509

-

Exercise of warrants

-

-

-

-

-

11,292

590

12,275

-

Repayment of notes payable

-

-

-

-

610

0

0

3,200

-

Debt issuance costs

714

320

0

50

218

0

-

-

-

Issuance of shares of Series E Convertible Preferred Stock

-

3,000

0

-

-

-

-

-

-

Additional borrowing from B3D

500

0

-

-

-

-

-

-

-

Payments on 5% Convertible Notes

129

0

-

-

-

-

-

-

-

Net proceeds from sale and issuance of shares of Common Stock in public offering

-

-

6,584

0

-

-

0

76,110

785

Repayment of debt and line of credit

-

-

-

2,011

-

-

-

-

-

Contributions from noncontrolling interests

178

250

316

0

-

-

-

-

-

Distributions to noncontrolling interests

1,197

1,636

452

0

-

-

-

-

-

Other

27

0

-

-

-

-

-

-

-

Net cash provided by financing activities - continuing operations

1,165

5,644

6,448

-2,061

11,597

-

-

-

-

Net cash provided by financing activities - discontinued operations

-

0

-361

0

-

-

-

-

-

Exercise of common stock options and warrants

-

-

-

-

-

-

-

-

8

Net cash provided by financing activities

1,165

5,644

6,087

-2,061

-

13,452

1,564

85,694

1,198

Effect of exchange rate changes

-32

-177

-61

-13

6

17

163

-2

-29

Decrease in cash, cash equivalents and restricted cash

-1,255

-2,965

-

-

-

-

-

-

-

Decrease in cash and cash equivalents

-

-

-11,542

-7,041

8,928

-17,563

-23,374

51,748

-4,217

Cash paid during the period for:
Interest

-

-

-

40

-

-

-

-

-

Interest

735

731

731

-

0

-

-

-

151

Income taxes

124

0

-

-

-

0

34

7

-

Non-cash investing and financing transactions
Issuance of shares of Common Stock for services

-

-

0

-

-

-

-

-

-

Debt discount related to issuance of convertible notes

-4,142

-1,962

-

-

2,961

0

-

-

-

Non-cash acquisition of cost method investment

-

-

-

-

-

787

0

0

-

Conversion of senior notes and warrants into Common Stock

3,494

0

-

-

-

1,707

808

10,657

-

Issuance of shares of Common Stock, preferred stock and warrants for the acquisition of XpresSpa

-

-

-908

35,666

0

-

-

-

-

Working capital (excluding cash and cash equivalents)

-

-

-

-

-454

0

-

-

-

Restricted cash

-

-

-

-

0

-

-

-

-

Property and equipment

-

-

-

-

0

-

-

-

-

Intangible assets

-

-

-

-

2,146

0

-

-

-

Goodwill

-

-

-

-

4,863

0

-

-

-

Deferred tax assets

-

-

-

-

0

-

-

-

-

Debt

-

-

-

-

0

-

-

-

-

Other liabilities

-

-

-

-

866

0

-

-

-

Extinguishment of debt

-

-

-

-356

-

-

-

-

-

Issuance of Series F Convertible Preferred Stock

1,131

0

1,809

0

5,833

0

-

-

213

Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants

-

-

-

-

175

0

-

-

-

Change in classification of derivative warrant liabilities into equity warrants

-

-

-

-

-

-

3,918

0

-

Issuance of shares of Common Stock to pay debt and interest

817

1,688

0

2,996

9,391

0

-

-

-

Conversion of Series D Convertible Preferred Stock to Common Stock

110

0

-

-

-

-

-

-

-

Conversion/exercise of warrants into Common Stock

17

0

-

-

-

-

-

-

-

Non-cash acquisition of cost method investment

-

2,075

0

-

-

-

-

-

-

Debt discount related to issuance of convertible notes

-4,142

-1,962

-

-

-

-

-

-

-

Debt discount related to issuance of convertible notes

-

-

0

-

-

-

-

-

-

Non-cash acquisition of construction-in-progress

-

228

1,154

-

-

-

-

-

-

Noncontrolling interests

-

-

-

-

0

-

-

-

-

Cash acquired as part of acquisition

-

-

26

2,114

144

0

0

3,326

-

Non-cash acquisition of patents through issuance of common stock (Note 6)

-

-

-

-

-

-

0

750

-

Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, prior to the Merger

-

-

-

-

-

-

0

76

-

Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, upon the Merger

-

-

-

-

-

-

0

1,724

-

Conversion of Series A Convertible Preferred stock, classified as equity, into common stock, after the Merger

-

-

-

-

-

-

0

201

-

Beneficial conversion feature recorded in connection with convertible notes

-

-

-

-

-

-

-

-

1,269